WATERS CORP /DE/ (WAT) Stock Price, Financials & Summary

Price chart

Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15

Key dataSep 15, 2026

Open$415.35

From 52W high−0.84%

Volume234377.00

Market cap$41.04B

P/E (TTM)103.9x

P/S (TTM)8.8x

Div yield—

Key dataSep 15, 2026

Open

$415.35

From 52W high

−0.84%

Volume

234377.00

Market cap

$41.04B

ValuationView details →

P/E (Fwd)

26.8x

EV/EBITDA

51.1x

P/E (TTM)

103.9x

RSI (14)

59.8

MomentumView details →

1D Return

+1.88%

YTD Return

+10.19%

SummaryUpdated Jul 1, 2026

Waters Corporation (NYSE:WAT) is a specialty measurement company founded in 1958 and headquartered in Milford, Massachusetts. The company went public in 1995 and has established itself as a leading provider of analytical workflow solutions serving laboratory applications across pharmaceutical, industrial, academic, and governmental sectors worldwide. Waters operates through two primary segments: Waters (analytical instruments) and TA (thermal analysis), delivering high-performance liquid chromatography, mass spectrometry, and thermal analysis systems to customers in Asia, the Americas, and Europe.

Ask drillr about WATERS CORP /DE/ →

ValuationView details →

P/E (Fwd)

26.8x

P/E (TTM)

103.9x

EV/EBITDA

51.1x

EV/Sales

9.9x

P/S (TTM)

8.8x

P/B (TTM)

2.7x

ProfitabilityView details →

Gross Margin

50.78%

Net Margin

3.58%

EBITDA Margin

19.29%

ROE (TTM)

1.09%

ROA (TTM)

0.67%

Asset Turnover

0.19x

GrowthView details →

Revenue YoY

+52.47%

EPS YoY

−63.88%

FCF YoY

−35.67%

Revenue CAGR 3Y

+2.12%

EPS CAGR 3Y

−2.91%

EBITDA YoY

−15.28%

MomentumView details →

1D Return

+1.88%

YTD Return

+10.19%

1Y Return

+38.10%

RSI (14)

59.8

vs 50D SMA

+5.82%

vs 200D SMA

+15.84%

Capital & dividendView details →

Debt/Equity

0.35x

Current Ratio

1.86x

Quick Ratio

1.29x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$3.05

EPS Surprise

1.33%

Beats (12Q)

12/12

Next Q EPS Est

$4.00

Avg Surprise (4Q)

7.32%

Rev Surprise

1.40%

Financials snapshotView financials →

Revenue (TTM)

4.64B

Net Income (TTM)

166.14M

Op. CF (TTM)

549.86M

Next earningsNov 3, 2026 →

Latest newsMore news →

Waters commercially launched the BD FACSDiscover A7 Cell Analyzer, a spectral flow cytometry instrument featuring BD SpectralFX and FACSTruQ technologies.1d ago

Robert L. Carpio III resigned as Senior Vice President of Waters Analytical Sciences Division, effective August 20, 2026.26d ago

Similar companies

IDEXX Laboratories, Inc.IDXX Agilent Technologies, Inc.A IQVIA Holdings Inc.IQV Hangzhou Tigermed Consulting Co., Ltd.03347.HK 昭衍新药603127.SH Natera, Inc.NTRA Find similar companies →

Latest newsMore news →

Waters commercially launched the BD FACSDiscover A7 Cell Analyzer, a spectral flow cytometry instrument featuring BD SpectralFX and FACSTruQ technologies.1d ago Robert L. Carpio III resigned as Senior Vice President of Waters Analytical Sciences Division, effective August 20, 2026.26d ago